At Novo Nordisk, we are driving change to defeat diabetes and other serious chronic conditions.
Novo Nordisk is a global healthcare company with more than 90 years of innovation and leadership in diabetes care. This heritage has given us experience and capabilities that also enable us to help people defeat other serious chronic conditions: diabetes, haemophilia, growth disorders and obesity.
Headquartered in Denmark, Novo Nordisk employs approximately 42,000 people in 77 countries and markets its products in more than 165 countries.
The Novo Nordisk Way is who we are, where we want to go and how we work. Each and every employee is responsible for acting in accordance with the Novo Nordisk Way - and to help each other understand what it means in practice.
The story of Novo Nordisk goes back 90 years. It began when August Krogh, a Nobel Prize-winning professor at the University of Copenhagen, decided he wanted to start producing a revolutionary new medical preparation called insulin.
This page is intended for members of the UK public
UK/WB/1215/0033(4) February 2017
We report on our financial, social and environmental performance in one integrated report.
Read our Annual Report